Nishikawa Akiyoshi, Nagano Kasuke, Kojima Hajime, Fukushima Shoji, Ogawa Kumiko
Division of Pathology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-shi, Kanagawa 210-9501, Japan.
Division of Clinical Pathology, Nagoya Tokushukai General Hospital, 2-52 Kouzoji-cho kita, Kasugai-shi, Aichi 487-0016, Japan.
J Toxicol Pathol. 2024 Jan;37(1):11-27. doi: 10.1293/tox.2023-0098. Epub 2023 Nov 1.
The pathogenesis of nasal cavity tumors induced in rodents has been critically reviewed. Chemical substances that induce nasal cavity tumors in rats, mice, and hamsters were searched in the National Toxicology Program (NTP), International Agency for Research on Cancer (IARC), and Japan Bioassay Research Center (JBRC) databases, in addition to PubMed. Detailed data such as animal species, administration routes, and histopathological types were extracted for induced nasal cavity tumors. Data on non-neoplastic lesions were also extracted. The relationship between the tumor type and non-neoplastic lesions at equivalent sites was analyzed to evaluate tumor pathogenesis. Genotoxicity data were also analyzed. Squamous cell carcinoma was the most frequent lesion, regardless of the dosing route, and its precursor lesions were squamous metaplasia and/or respiratory epithelial hyperplasia, similar to squamous cell papilloma. The precursor lesions of adenocarcinoma, the second most frequent tumor type, were mainly olfactory epithelial hyperplasia, whereas those of adenoma were respiratory epithelial lesions. These pathways were consistent among species. Our results suggest that the responsible lesions may be commonly linked with chemically-induced cytotoxicity in each tumor type, irrespective of genotoxicity, and that the pathways may largely overlap between genotoxic and non-genotoxic carcinogens. These findings may support the documentation of adverse outcome pathways (AOPs), such as cytotoxicity, leading to nasal cavity tumors and the integrated approaches to testing and assessment (IATA) for non-genotoxic carcinogens.
对啮齿动物诱发鼻腔肿瘤的发病机制进行了严格审查。除了PubMed之外,还在国家毒理学计划(NTP)、国际癌症研究机构(IARC)和日本生物测定研究中心(JBRC)数据库中搜索了可在大鼠、小鼠和仓鼠中诱发鼻腔肿瘤的化学物质。提取了诱发鼻腔肿瘤的详细数据,如动物种类、给药途径和组织病理学类型。还提取了非肿瘤性病变的数据。分析了等效部位肿瘤类型与非肿瘤性病变之间的关系,以评估肿瘤发病机制。还分析了遗传毒性数据。无论给药途径如何,鳞状细胞癌是最常见的病变,其前驱病变为鳞状化生和/或呼吸上皮增生,类似于鳞状细胞乳头状瘤。第二常见的肿瘤类型腺癌的前驱病变主要是嗅上皮增生,而腺瘤的前驱病变是呼吸上皮病变。这些途径在不同物种间是一致的。我们的结果表明,每种肿瘤类型中,无论遗传毒性如何,相关病变可能通常与化学诱导的细胞毒性有关,并且这些途径在遗传毒性致癌物和非遗传毒性致癌物之间可能有很大重叠。这些发现可能支持不良结局途径(AOP)的记录,如导致鼻腔肿瘤的细胞毒性,以及非遗传毒性致癌物的综合测试与评估方法(IATA)。